IV hydration clinics and med spas are expanding across Virginia. While many offer a convenient, consumer-friendly model, the Virginia Department of Health Professions (DHP) makes clear in recent guidance that “IV hydration clinics and med spas that allow patients to select treatments from a menu, complete a brief questionnaire, and undergo a basic screening by a nurse or unlicensed staff member may be operating in an illegal and unsafe manner.” Guidance Document 76-1, “Regulatory Considerations for IV Hydration Clinics and Med Spas in Virginia” (the “Guidance Document”), effective October 8, 2026, summarizes laws and regulations enforced by the state Board of Medicine, Board of Nursing, and Board of Pharmacy. How to avoid the pitfalls? Read on.
On November 9, 2026, the Centers for Medicare & Medicaid Services (CMS) published its final Calendar Year 2027 Physician Fee Schedule rule (CMS-1848-F). Alongside the physician payment updates, the rule makes significant changes to the Medicare Shared Savings Program (MSSP). Most of the changes take effect January 1, 2027, and several affect decisions that accountable care organizations (ACOs) must make this year.
On November 5, 2026, the Centers for Medicare & Medicaid Services (CMS) issued a rule (the “Proposed Rule”) that would cut certain administrative requirements from the Conditions of Participation (CoPs), Conditions for Coverage (CfCs), and Requirements for Participation for Medicare- and Medicaid-participating providers and suppliers (collectively referred to as CoPs).
When a senior living or skilled nursing facility gets into financial trouble, restructuring professionals and lenders must account for the structural pressures faced by all long-term care facilities. At the American Bankruptcy Institute’s Healthcare Program in Washington, D.C., in October 2026, Ryan Cochran moderated a panel, “Structural Pressures Driving Distress,” with senior living operators that discussed outside forces that strain all operators.
On October 20, 2026, the Centers for Medicare & Medicaid Services (CMS) published a Proposed Rule (the “Proposed Rule”) to amend regulations pursuant to the mandates of Section 6224 of the Consolidated Appropriations Act of 2026 (CAA), signed into law on February 3, 2026. Section 6224 adds new and enhanced requirements under the Medicare Part D program aimed at pharmacy benefit managers (PBMs) and their affiliates, addressing issues such as how PBMs are compensated and how much data they must share about their operations. Procedurally, Section 6224 amends section 1860D–12 of the Social Security Act (42 U.S.C. § 1395w–112) to add these new and enhanced requirements. With its Proposed Rule, CMS is codifying these changes in regulation.
On October 19, 2026, the U.S. Food and Drug Administration (FDA) issued final guidance (the “Final Guidance”) on identity and safety information for New Dietary Ingredient Notifications (NDINs). FDA’s New Dietary Ingredient (NDI) Notifications and Related Issues; Identity and Safety Information About the NDI finalizes the identity, history of use, and safety summary sections of FDA’s 2016 revised Draft Guidance.[1] For companies preparing to bring a new ingredient to market, it is the most concrete statement yet of what FDA expects to see in a notification. Industry has long asked for that clarity, and this release is a meaningful step toward it. However, the Final Guidance still fails to address fundamental questions regarding when an NDIN is even required, leaving the industry still a bit perplexed on how to navigate the field.
In the latest from the U.S. Department of Justice (DOJ), the National Fraud Enforcement Division (NFED) announced on October 20, 2026, the creation of a Fraud Whistleblower Incentive Program (WHIP)[1] paying between $10,000 and $30,000 for information leading to criminal charges—to be handed out at the charging stage of a criminal case, as opposed to after the final resolution. This program further incentivizes private whistleblowers to voluntarily disclose potential fraudulent activity. Health care companies, in particular, need to be aware of what this may mean for their businesses.
In the latest wave of press releases ramping up the new National Fraud Enforcement Division (NFED), the Department of Justice (DOJ) and the Department of Health and Human Services Office of Inspector General (HHS-OIG) announced a new policy (the “Coordination Policy”) on October 15, 2026, directing that companies seeking to voluntarily self-disclose potential criminal conduct relating to health care should now make self-disclosures to NFED.
Such disclosures will automatically trigger both DOJ’s Corporate Enforcement and Voluntary Self-Disclosure Policy (CEP) and HHS-OIG’s Health Care Fraud Self-Disclosure Protocol (SDP).
A company disclosing only to HHS-OIG generally will not receive the benefits of DOJ’s CEP covering criminal conduct and will not be deemed to have made a voluntary self-disclosure to DOJ. This is critical, since a voluntary self-disclosure to DOJ could qualify a company for a declination. Consequently, companies seeking the benefits of both programs should disclose potentially criminal conduct to NFED first.
What You Need to Know
- A new civil False Claims Act (FCA) Self-Disclosure Pilot Program (SDPP) was announced on October 22, 2026.
- The SDPP, which will run for six months, encourages health care entities to self-disclose potential violations of the FCA and reach resolution on civil liability as well as various administrative penalties.
- The SDPP offers several favorable terms for entities participating in the SDPP, including a lower multiplier and non-claims based calculation methodology for disclosed Anti-Kickback Statute (AKS) violations.
It was an invigorating conference at Horizons: Perspectives on Psychedelics, October 15–17, 2026, in New York, which featured important views on the health care industry, federal agency preparation for psychedelic drug regulation, reimbursement, and incorporating psychedelics into patient care protocols.
This post shares insights that the Epstein Becker Green team took away from sitting in on these discussions.
Recent Updates
- What Virginia’s New Guidance Means for IV Hydration Clinics and Med Spas
- What CMS's 2027 Fee Schedule Changes Mean for Shared Savings Program ACOs
- CMS Wants to End Certain COVID Requirements, Natural Light in Patient Care Areas: Proposed Rule Would Update CoPs for Hospitals, LTC Facilities, and Other Providers
- The Structural Pressures Behind Senior Living and Long-Term Care Distress
- CMS Proposed Rule to Implement Section 6224 of the Consolidated Appropriations Act